Solid Biosciences (SLDB) Other Working Capital Changes (2017 - 2026)

Solid Biosciences has disclosed Other Working Capital Changes across 10 years of filings, most recently posting $362.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $362.0, up 100.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $362.0 (up 100.08% YoY), and the FY2025 annual result was $194390.0, up 336.63% from the prior year.
• Other Working Capital Changes came in at $362.0 for Q1 2026 at Solid Biosciences, down from $7.6 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $7.6 million in Q4 2025 to a low of -$4.8 million in Q4 2022.
• The 5-year median for Other Working Capital Changes is $362.0 (2026), against an average of -$94504.5.
• Across the five-year window, Other Working Capital Changes plunged 162.82% in 2022 and soared 7454.81% in 2025, its largest moves.
• Solid Biosciences' Other Working Capital Changes stood at -$4.8 million in 2022, then jumped by 111.01% to $526000.0 in 2023, then plunged by 119.77% to -$104000.0 in 2024, then jumped by 7454.81% to $7.6 million in 2025, then sank by 100.0% to $362.0 in 2026.
• The last three Other Working Capital Changes figures came in at $362.0 (Q1 2026), $7.6 million (Q4 2025), and $192579.0 (Q3 2025), per Business Quant data.